Formulation Development

Formulation Development

Products
Formulation Development
Formulation Development

Information

Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development. - Formulations design - Pre-formulation screening - First-in-human - Solubility enhancement - Modified release - Analytical Services - Process optimization & scale-up - Gamma scintigraphy
Product Categories
  • Pharmaceutical Machinery & Technology
    • Drug Formulation (general category)
    Service Categories
    • Contract Research Organisations (CROs)
      • Clinical Data Management
      Distribution Areas
      OceaniaNorth America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
      Supplied From
      United KingdomUnited States
      Quotient SciencesQuotient Sciences brings 35+ years of trusted scientific insight, quality, and control to drug development with a mission to help our customers bring new molecules to patients faster. We provide a full range of drug product (CDMO) and clinical (CRO) services, which can be tightly integrated with Translational Pharmaceutics(R)—a disruptive platform to enable greater efficiency, better outcomes, and reduced timelines in development.

      Log in

      See all the content and easy-to-use features by logging in or registering!